Keyword → GSK

London’s FTSE 100 Dips as Standard Chartered and BP Weigh on Markets

The FTSE 100 index slipped on February 10, pressured by sharp share price declines at Standard Chartered and BP, with broader investor caution amid earnings and governance concerns. While some heavyweight stocks rose, energy sector headwinds and executive turnover unsettled sentiment in European markets.

Philips Reports 2025 Results With Margin Expansion and 2026 Outlook Targets

Royal Philips published its full-year 2025 financial results, highlighting accelerated growth, expanding profit margins and robust cash flow. The company also unveiled strategic targets for 2026-2028, emphasizing innovation and operational efficiency across health technology segments.

London’s FTSE 100 Index Declines on Sector Weakness Despite Broader Risk Appetite

The FTSE 100 index fell 0.4% on January 28, 2026, pressured by declines in healthcare and banking stocks, offset partially by gains in the FTSE 250 and energy sectors. Pharmaceutical giants and major lenders slid amid mixed earnings data and profit taking, while miners and energy companies found support. Market participants maintained focus on upcoming earnings and U.S. monetary policy developments influencing global sentiment.